According to a recent market study published by Growth Market Reports, titled, "Global Nattokinase Market by applications, by distribution channel, and by regions: Size, Share, Trends and Opportunity Analysis, 2017-2027", the market was valued at USD 29.5 Million in 2019 and is expected to grow at a rate of 2.6% by 2027. The nattokinase market is anticipated to grow significantly during the forecast period.

Changing lifestyles and lack of physical activity, rising consumer awareness regarding health, increasing demand for plant source supplements, and growing prevalence of cardiovascular diseases are some of the factors contributing to the market growth.

The global nattokinase market has been segmented into applications, distribution channel, and regions. In terms of applications, the nattokinase market is divided into food, dietary supplement, and cosmetics. Based on distribution channel, the nattokinase market is categorized as online and offline. On the basis of regions, the job description management software market is segmented as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Request a free sample copy:

Increasing number of chronic diseases such as cancer, diabetes, and strokes, due to changing lifestyles and lack of physical exercise is expected to drive the market during the forecast period. Nattokinase is used as a dietary supplement and a functional food and helps to reduce cholesterol level in the body. Lack of physical activity leads to obesity, type 2 diabetes, some types of cancer, cardiovascular disease, and early death. Consumption of nattokinase helps reduce prevalence of chronic diseases.

Rising consumer awareness regarding health is anticipated to propel the market in the coming years. Population in developed and developing countries has several health concerns. Nattokinase is a natural supplement that is consumed orally, has a well-established safety profile, is cost-effective, and has specific advantages over other medicines. Consumers are becoming health-conscious and trying health and dietary supplements. Nattokinase is easily available in the form of tablets, powder, and liquid in various supermarkets as well as on e-commerce websites.

Special precautions/warning and side effects of nattokinase include its function as a "blood thinner" and bleeding issues. Blood pressure is expected to be reduced by nattokinase, which acts as a concern if blood pressure is already too low. Nattokinase is expected to raise concerns for pregnant women or while breastfeeding. Additionally, lack of credible information about nattokinase is expected to hinder the market growth during the forecast period.

The outbreak of COVID-19 put huge stress on the nattokinase market across the globe. The pandemic affected all businesses and GDP fell significantly. People are concentrating on buying daily needs products, instead of health supplements, as per capita income reduced along with GDP. The demand for nattokinase is projected to depend on the rising demand for health supplements and consumer awareness regarding health. Post COVID-19 pandemic, the demand for nattokinase is anticipated to return to normality, which is expected to lead to the recovery of demand for nattokinase.

The market in Asia Pacific is expected to expand at a considerable CAGR during the forecast period, due to rising awareness about health benefits associated with nattokinase. Increasing population, rising prevalence of cardiovascular diseases, and surge in hypertension are the major factors fueling the market in the region. Australia, Japan, India, and China are the potential markets for in Asia Pacific.

Key Takeaways from the Study

  • North America is expected to grow significantly during the forecast period, due to factors such as increasing hypertensive population and rising prevalence of chronic diseases, owing to changing lifestyles.
  • Europe region holds substantial share in the market during the forecast period, due to the due to local presence of various leading companies.
  • The market in Asia Pacific is expected to expand at a considerable CAGR during the forecast period, due to increasing population, rising prevalence of cardiovascular diseases, and surge in hypertension.
  • The dietary segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, owing to increasing prevalence of several cardiovascular diseases, including heart disease, stroke, hypertension, high cholesterol, deep vein thrombosis (DVT), and chest pain (angina). The working population across the globe is failing to reach daily nutrient requirements, due to hectic work schedules and changing lifestyles. This is raising the demand for dietary supplements to meet nutrient requirements due to high convenience, which is anticipated to boost the market over the forecast period.
  • The online segment is expected to expand at a significant pace during the forecast period, due to rising number of internet users, increasing penetration of the internet across the globe, and favorable rules and regulations by the government to support online businesses. COVID-19 resulted in a surge in e-commerce amid slowing economic activity.

Report Scope

Report Metric


Market Value in 2019

USD 29.5 Million

Market Growth Rate (from 2020 to 2027)


Historical Data

2017 & 2018

Base Year


Forecast Period

2020 – 2027

Market Segments

Applications, Distribution Channels, and Regions.

Region Scope

North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Key Companies Profiled

GeneFerm Biotechnology Co., Ltd., Japan Bio Science Laboratory CO. Ltd, Belle Chemical, and Sungen Bioscience Co.,Ltd,.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience

  • Demand Side: Healthcare Industry, Pharmaceutical Company, Food & Beverages, and others.
  • Regulatory Side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies.
  • Associations and Industry Bodies: Food & Drug Administration (FDA), European Food Safety Authority (EFSA), FSSAI, and Others.